Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

US hospital group Agreement

18th Dec 2006 07:01

Surgical Innovations Group PLC18 December 2006 Press Release 18 December 2006 Surgical Innovations Group plc ("Surgical" or "the Group") Provider of Choice for major US hospital group Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer ofinnovative surgical devices, today announces that it has been approved by theNorth Shore Long Island Jewish Health System ("North Shore") as an accreditedsupplier of laparoscopic equipment. Following extensive trials across all disciplines of laparoscopic surgery withinthe North Shore hospital group, the Group's market-leading 'resposable' (amixture of both reusable and disposable items) and versatile YelloPort abdominalaccess system will be supplied to operating theatres in pre-prepared equipmenttrays, tailored to each type of operation. North Shore is the USA's third-largest non-profit secular healthcare systemsgroup, comprising 15 hospitals, with in excess of 6,000 beds. With a US$4billion annual operating budget and more than 38,000 employees, North Shoreservices an area of 5.2 million people in New York State. North Shore treats more than 235,000 in-patients annually and offers a fullspectrum of advanced minimally invasive procedures. There are 4.4 millionlaparoscopic surgical procedures carried out each year in the US (Source:Patient Safety and Quality Healthcare journal, May/June 2005) and the worldwidedemand for such operations is escalating with the majority of countries nowundertaking these procedures on a routine basis. Graham Bowland, Joint Managing Director of Surgical Innovations, commented: "Weare delighted to have been accredited by North Shore and look forward to furtheropportunities to demonstrate our range of surgical instruments. We believe thisis a positive step in the growth of the Group and are confident that thisinvaluable endorsement from pre-eminent surgeons at a respected hospital groupwill help us gain accredited supplier status in further hospitals across theUSA." - Ends - For further information: Surgical Innovations Group plc Graham Bowland, Managing Director Tel: +44 (0) 113 230 7597 [email protected] www.sigroupplc.com Hanson Westhouse LLP Tim Feather Tel: +44 (0) 113 246 2610 [email protected] www.hansonwesthouse.com Media enquiries: Abchurch Gareth Mead / Justin Heath Tel: +44 (0) 20 7398 7710 [email protected] www.abchurch-group.com Notes to Editors: Surgical Innovations Group plc specialises in the design and manufacture ofinnovative devices for use in minimally invasive surgery and industrial markets. The Group employs over 50 people and is headquartered in Leeds. The Group's medical division is focused on strong international growth in twospecialist areas namely minimally invasive surgery, where products are used in'keyhole' surgery which is more accurately known as laparoscopic surgery, andproducts for autologous blood transfusion whereby a patient's own blood isrecycled. The Group's industrial division utilises Surgical Innovations' core medicaldevice design expertise and technology in innovative engineering applications. For more information, see www.sigroupplc.com This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Surgical Innovations
FTSE 100 Latest
Value8,809.74
Change53.53